home / stock / lab / lab news


LAB News and Press, Standard BioTools Inc. From 04/25/24

Stock Information

Company Name: Standard BioTools Inc.
Stock Symbol: LAB
Market: NASDAQ

Menu

LAB LAB Quote LAB Short LAB News LAB Articles LAB Message Board
Get LAB Alerts

News, Short Squeeze, Breakout and More Instantly...

LAB - Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLO...

LAB - Labrador Gold Announces Sale of Kingsway Project

TORONTO, April 22, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“ LabGold ” or the “ Company ”) is pleased to announce that it has entered into a property purchase agreement (the “ Definitive Agreement ”) ...

LAB - Labrador Gold Files NI43-101 Technical Report for the Kingsway Project

TORONTO, April 17, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce the completion and filing of an independent technical report ("NI43-101 Report") prepared in accordance with Nationa...

LAB - Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the introduction of new solutions that add automation and flexibilit...

LAB - Standard Biotools enters strategic engagement with Bristol Myers for expanded use of Somascan platform

2024-04-03 16:10:28 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript Standard BioTools exchanges all outstanding Series B convertible preferred stock for common stock Standard BioTools expects over 10% growth in 2023 core rev...

LAB - Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that it has entered into a multi-year engagement with glob...

LAB - Labrador Gold: High-Grade Gold in Newfoundland

2024-03-27 17:08:02 ET CEO of Labrador Gold, Roger Moss, talks about potential high-grade gold discoveries in Newfoundland Labrador Gold 's main focus is gold exploration in Eastern Canada. Overall, the company has 4 projects, 1 in Ontario, 2 in Labrador; and more recently an ...

LAB - Labrador Gold: Exploration in Newfoundland

2024-03-27 17:08:02 ET Potential for high-grade gold discoveries at its project in Newfoundland Labrador Gold is a Canadian based mineral exploration company. They're focusing on the acquisition and exploration of prospective gold projects in Eastern Canada. In early March 202...

LAB - Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

2024-03-20 04:33:40 ET Summary Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological adva...

LAB - Standard Biotools exchanges all outstanding Series B convertible preferred stock for common stock

2024-03-18 09:37:53 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript Standard BioTools expects over 10% growth in 2023 core revenue Standard BioTools, SomaLogic fall after shareholder nod for merger Seeking Alpha ...

Previous 10 Next 10